BackVanda Pharmaceuticals Overview

Vanda Pharmaceuticals Total Revenue

Revenue analysis for VNDA.

Quarterly Revenue

$51.72M
↑ 3.35% YoY

As of Mar 2026

Annual Revenue (TTM)

$217.78M
↑ 8.16% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin